BCAS1 and glioblastoma: In the present study, we found that BCAS1-SV1 binding to β-arrestin 2 may hinder its tumor suppressor function, which may be one of the main reasons for the growth and migration of GBM and makes BCAS1-SV1 an excellent target for the development of therapeutic agents.